The market is mainly driven by the significant applications of Antisense and RNAi Therapeutics in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Antisense and RNAi Therapeutics market. RNA Interference, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antisense RNA segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antisense and RNAi Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Antisense and RNAi Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Antisense and RNAi Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antisense and RNAi Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Antisense and RNAi Therapeutics covered in this report include Tekmira Pharmaceuticals, Arbutus Biopharma, Alnylam Pharmaceuticals, Antisense Therapeutics, Silence Therapeutics, Isis Pharmaceuticals, Sirnaomics, Santaris and Roche, etc.

The global Antisense and RNAi Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Tekmira Pharmaceuticals

Arbutus Biopharma

Alnylam Pharmaceuticals

Antisense Therapeutics

Silence Therapeutics

Isis Pharmaceuticals

Sirnaomics

Santaris

Roche

Scope of Antisense and RNAi Therapeutics - Market Report

Report Metric	Details
Report Name	Antisense and RNAi Therapeutics - Market
Forecasted market size in 2029	US$ 1881.9 million
CAGR	5.5%
Forecasted years	2023 - 2029
Global Antisense and RNAi Therapeutics market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antisense and RNAi Therapeutics market, Segment by Type:	RNA Interference Antisense RNA
Global Antisense and RNAi Therapeutics market, by Application	Hospital Clinic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antisense and RNAi Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Antisense and RNAi Therapeutics - Market size in 2029?

Ans: The Antisense and RNAi Therapeutics - Market size in 2029 will be US$ 1881.9 million.

What are the Application segmentation covered in the Antisense and RNAi Therapeutics - Market report?

Ans: The Applications covered in the Antisense and RNAi Therapeutics - Market report are Hospital, Clinic

What are the Type segmentation covered in the Antisense and RNAi Therapeutics - Market report?

Ans: The Types covered in the Antisense and RNAi Therapeutics - Market report are RNA Interference, Antisense RNA

1 Market Overview of Antisense and RNAi Therapeutics

1.1 Antisense and RNAi Therapeutics Market Overview

1.1.1 Antisense and RNAi Therapeutics Product Scope

1.1.2 Antisense and RNAi Therapeutics Market Status and Outlook

1.2 Global Antisense and RNAi Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Antisense and RNAi Therapeutics Market Size by Region (2018-2029)

1.4 Global Antisense and RNAi Therapeutics Historic Market Size by Region (2018-2023)

1.5 Global Antisense and RNAi Therapeutics Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Antisense and RNAi Therapeutics Market Size (2018-2029)

1.6.1 North America Antisense and RNAi Therapeutics Market Size (2018-2029)

1.6.2 Europe Antisense and RNAi Therapeutics Market Size (2018-2029)

1.6.3 Asia-Pacific Antisense and RNAi Therapeutics Market Size (2018-2029)

1.6.4 Latin America Antisense and RNAi Therapeutics Market Size (2018-2029)

1.6.5 Middle East & Africa Antisense and RNAi Therapeutics Market Size (2018-2029)

2 Antisense and RNAi Therapeutics Market by Type

2.1 Introduction

2.1.1 RNA Interference

2.1.2 Antisense RNA

2.2 Global Antisense and RNAi Therapeutics Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Antisense and RNAi Therapeutics Historic Market Size by Type (2018-2023)

2.2.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Antisense and RNAi Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Antisense and RNAi Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Antisense and RNAi Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Antisense and RNAi Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Antisense and RNAi Therapeutics Revenue Breakdown by Type (2018-2029)

3 Antisense and RNAi Therapeutics Market Overview by Application

3.1 Introduction

3.1.1 Hospital

3.1.2 Clinic

3.2 Global Antisense and RNAi Therapeutics Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Antisense and RNAi Therapeutics Historic Market Size by Application (2018-2023)

3.2.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Antisense and RNAi Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Antisense and RNAi Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Antisense and RNAi Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Antisense and RNAi Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Antisense and RNAi Therapeutics Revenue Breakdown by Application (2018-2029)

4 Antisense and RNAi Therapeutics Competition Analysis by Players

4.1 Global Antisense and RNAi Therapeutics Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2022)

4.3 Date of Key Players Enter into Antisense and RNAi Therapeutics Market

4.4 Global Top Players Antisense and RNAi Therapeutics Headquarters and Area Served

4.5 Key Players Antisense and RNAi Therapeutics Product Solution and Service

4.6 Competitive Status

4.6.1 Antisense and RNAi Therapeutics Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Tekmira Pharmaceuticals

5.1.1 Tekmira Pharmaceuticals Profile

5.1.2 Tekmira Pharmaceuticals Main Business

5.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

5.1.4 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.1.5 Tekmira Pharmaceuticals Recent Developments

5.2 Arbutus Biopharma

5.2.1 Arbutus Biopharma Profile

5.2.2 Arbutus Biopharma Main Business

5.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Products, Services and Solutions

5.2.4 Arbutus Biopharma Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.2.5 Arbutus Biopharma Recent Developments

5.3 Alnylam Pharmaceuticals

5.3.1 Alnylam Pharmaceuticals Profile

5.3.2 Alnylam Pharmaceuticals Main Business

5.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

5.3.4 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.3.5 Antisense Therapeutics Recent Developments

5.4 Antisense Therapeutics

5.4.1 Antisense Therapeutics Profile

5.4.2 Antisense Therapeutics Main Business

5.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Products, Services and Solutions

5.4.4 Antisense Therapeutics Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.4.5 Antisense Therapeutics Recent Developments

5.5 Silence Therapeutics

5.5.1 Silence Therapeutics Profile

5.5.2 Silence Therapeutics Main Business

5.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Products, Services and Solutions

5.5.4 Silence Therapeutics Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.5.5 Silence Therapeutics Recent Developments

5.6 Isis Pharmaceuticals

5.6.1 Isis Pharmaceuticals Profile

5.6.2 Isis Pharmaceuticals Main Business

5.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

5.6.4 Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.6.5 Isis Pharmaceuticals Recent Developments

5.7 Sirnaomics

5.7.1 Sirnaomics Profile

5.7.2 Sirnaomics Main Business

5.7.3 Sirnaomics Antisense and RNAi Therapeutics Products, Services and Solutions

5.7.4 Sirnaomics Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.7.5 Sirnaomics Recent Developments

5.8 Santaris

5.8.1 Santaris Profile

5.8.2 Santaris Main Business

5.8.3 Santaris Antisense and RNAi Therapeutics Products, Services and Solutions

5.8.4 Santaris Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.8.5 Santaris Recent Developments

5.9 Roche

5.9.1 Roche Profile

5.9.2 Roche Main Business

5.9.3 Roche Antisense and RNAi Therapeutics Products, Services and Solutions

5.9.4 Roche Antisense and RNAi Therapeutics Revenue (US$ Million) & (2018-2023)

5.9.5 Roche Recent Developments

6 North America

6.1 North America Antisense and RNAi Therapeutics Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Antisense and RNAi Therapeutics Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Antisense and RNAi Therapeutics Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Antisense and RNAi Therapeutics Market Dynamics

11.1 Antisense and RNAi Therapeutics Industry Trends

11.2 Antisense and RNAi Therapeutics Market Drivers

11.3 Antisense and RNAi Therapeutics Market Challenges

11.4 Antisense and RNAi Therapeutics Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Silence Therapeutics

Sirnaomics

Tekmira Pharmaceuticals

Arbutus Biopharma

Alnylam Pharmaceuticals

Antisense Therapeutics

Isis Pharmaceuticals

Santaris

Roche

List of Tables

Table 1. Global Market Antisense and RNAi Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Antisense and RNAi Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Antisense and RNAi Therapeutics Market Size Share by Region (2018-2023)

Table 4. Global Antisense and RNAi Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Antisense and RNAi Therapeutics Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Antisense and RNAi Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Antisense and RNAi Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2023)

Table 9. Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2024-2029)

Table 11. North America Antisense and RNAi Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Antisense and RNAi Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Antisense and RNAi Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Antisense and RNAi Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Antisense and RNAi Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Antisense and RNAi Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Antisense and RNAi Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Antisense and RNAi Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Antisense and RNAi Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Antisense and RNAi Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Antisense and RNAi Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Antisense and RNAi Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2023)

Table 24. Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Antisense and RNAi Therapeutics Revenue Market Share by Application (2024-2029)

Table 26. North America Antisense and RNAi Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Antisense and RNAi Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Antisense and RNAi Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Antisense and RNAi Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Antisense and RNAi Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Antisense and RNAi Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Antisense and RNAi Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Antisense and RNAi Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Antisense and RNAi Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Antisense and RNAi Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Antisense and RNAi Therapeutics Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2022)

Table 39. Date of Key Players Enter into Antisense and RNAi Therapeutics Market

Table 40. Global Antisense and RNAi Therapeutics Key Players Headquarters and Area Served

Table 41. Antisense and RNAi Therapeutics Product Solution and Service

Table 42. Global Antisense and RNAi Therapeutics Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Tekmira Pharmaceuticals Basic Information List

Table 45. Tekmira Pharmaceuticals Description and Business Overview

Table 46. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

Table 47. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Tekmira Pharmaceuticals (2018-2023)

Table 48. Tekmira Pharmaceuticals Recent Developments

Table 49. Arbutus Biopharma Basic Information List

Table 50. Arbutus Biopharma Description and Business Overview

Table 51. Arbutus Biopharma Antisense and RNAi Therapeutics Products, Services and Solutions

Table 52. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Arbutus Biopharma (2018-2023)

Table 53. Arbutus Biopharma Recent Developments

Table 54. Alnylam Pharmaceuticals Basic Information List

Table 55. Alnylam Pharmaceuticals Description and Business Overview

Table 56. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

Table 57. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Alnylam Pharmaceuticals (2018-2023)

Table 58. Alnylam Pharmaceuticals Recent Developments

Table 59. Antisense Therapeutics Basic Information List

Table 60. Antisense Therapeutics Description and Business Overview

Table 61. Antisense Therapeutics Antisense and RNAi Therapeutics Products, Services and Solutions

Table 62. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Antisense Therapeutics (2018-2023)

Table 63. Antisense Therapeutics Recent Developments

Table 64. Silence Therapeutics Basic Information List

Table 65. Silence Therapeutics Description and Business Overview

Table 66. Silence Therapeutics Antisense and RNAi Therapeutics Products, Services and Solutions

Table 67. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Silence Therapeutics (2018-2023)

Table 68. Silence Therapeutics Recent Developments

Table 69. Isis Pharmaceuticals Basic Information List

Table 70. Isis Pharmaceuticals Description and Business Overview

Table 71. Isis Pharmaceuticals Antisense and RNAi Therapeutics Products, Services and Solutions

Table 72. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Isis Pharmaceuticals (2018-2023)

Table 73. Isis Pharmaceuticals Recent Developments

Table 74. Sirnaomics Basic Information List

Table 75. Sirnaomics Description and Business Overview

Table 76. Sirnaomics Antisense and RNAi Therapeutics Products, Services and Solutions

Table 77. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Sirnaomics (2018-2023)

Table 78. Sirnaomics Recent Developments

Table 79. Santaris Basic Information List

Table 80. Santaris Description and Business Overview

Table 81. Santaris Antisense and RNAi Therapeutics Products, Services and Solutions

Table 82. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Santaris (2018-2023)

Table 83. Santaris Recent Developments

Table 84. Roche Basic Information List

Table 85. Roche Description and Business Overview

Table 86. Roche Antisense and RNAi Therapeutics Products, Services and Solutions

Table 87. Revenue (US$ Million) in Antisense and RNAi Therapeutics Business of Roche (2018-2023)

Table 88. Roche Recent Developments

Table 89. North America Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 90. North America Antisense and RNAi Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 91. Europe Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 92. Europe Antisense and RNAi Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 93. Asia-Pacific Antisense and RNAi Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 94. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 95. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 96. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Region (2018-2023)

Table 97. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Region (2024-2029)

Table 98. Latin America Antisense and RNAi Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Latin America Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 100. Latin America Antisense and RNAi Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 101. Middle East & Africa Antisense and RNAi Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 102. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 103. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 104. Antisense and RNAi Therapeutics Market Trends

Table 105. Antisense and RNAi Therapeutics Market Drivers

Table 106. Antisense and RNAi Therapeutics Market Challenges

Table 107. Antisense and RNAi Therapeutics Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antisense and RNAi Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Antisense and RNAi Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Antisense and RNAi Therapeutics Market Share by Regions: 2022 VS 2029

Figure 4. Global Antisense and RNAi Therapeutics Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Antisense and RNAi Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Antisense and RNAi Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Antisense and RNAi Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Antisense and RNAi Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Antisense and RNAi Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of RNA Interference

Figure 11. Global RNA Interference Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Antisense RNA

Figure 13. Global Antisense RNA Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Antisense and RNAi Therapeutics Market Size Share by Type: 2022 & 2029

Figure 15. North America Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2029)

Figure 16. Europe Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2029)

Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Global Antisense and RNAi Therapeutics Market Size Share by Application: 2022 & 2029

Figure 23. North America Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2029)

Figure 24. Europe Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2029)

Figure 25. Asia-Pacific Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2029)

Figure 26. Latin America Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2029)

Figure 27. Middle East and Africa Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2029)

Figure 28. Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 29. Global Top 5 and Top 10 Players Antisense and RNAi Therapeutics Market Share in 2022

Figure 30. North America Antisense and RNAi Therapeutics Market Share by Country (2018-2029)

Figure 31. U.S. Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 32. Canada Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 33. Germany Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 34. France Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 35. U.K. Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 36. Italy Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 37. Russia Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 38. Nordic Countries Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 39. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Region (2018-2029)

Figure 40. China Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 41. Japan Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 42. South Korea Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 44. India Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 45. Australia Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 46. Latin America Antisense and RNAi Therapeutics Market Share by Country (2018-2029)

Figure 47. Mexico Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 48. Brazil Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 49. Middle East & Africa Antisense and RNAi Therapeutics Market Share by Country (2018-2029)

Figure 50. Turkey Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 51. Saudi Arabia Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 52. UAE Antisense and RNAi Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 53. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions